Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
Results released by the U.S. Government (USG) in September reveal that since fiscal year (FY) 2009, more than $50 billion has been invested by the USG in foreign assistance for health, saving millions of lives.
What do neglected tropical diseases (NTDs) have to do with women’s health? A recent review entitled, “Effective Health Interventions for Adolescents That Could Be Integrated with Human Papillomavirus Vaccination Programs”, has just been published looking at how combining multiple health interventions with human papillomavirus (HPV) vaccinations increases the effectiveness of HPV delivery.
Last week, the High-Level Panel of Eminent Persons on the Post-2015 Development Agenda released a report – A New Global Partnership: Eradicate Poverty and Transform Economics through Sustainable Development.
Earlier this month, the journal PLoS Neglected Tropical Diseases published some very exciting news – Togo is about to become the first sub-Saharan African country to eliminate lymphatic filariasis (LF), a painful and disabling neglected tropical disease (NTD) also known as elephantiasis.